INVIVOMAB Trademark

Trademark Overview

On Friday, April 12, 2013, a trademark application was filed for INVIVOMAB with the United States Patent and Trademark Office. The USPTO has given the INVIVOMAB trademark a serial number of 85902767. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Wednesday, September 19, 2018. This trademark is owned by Bio X Cell. The INVIVOMAB trademark is filed in the Chemical Products category with the following description:

Biochemicals, namely, monoclonal antibodies that are low in endotoxins and do not contain azide or carrier proteins for in-vivo scientific research

General Information

Serial Number85902767
Word MarkINVIVOMAB
Filing DateFriday, April 12, 2013
Status701 - SECTION 8 - ACCEPTED
Status DateWednesday, September 19, 2018
Registration Number4405006
Registration DateTuesday, September 17, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiochemicals, namely, monoclonal antibodies that are low in endotoxins and do not contain azide or carrier proteins for in-vivo scientific research
Pseudo MarkINVIVOM AB

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, April 18, 2013
Primary Code001
First Use Anywhere DateTuesday, January 1, 2013
First Use In Commerce DateTuesday, January 1, 2013

Trademark Owner History

Party NameBIO X CELL, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressLEBANON, NH 03766
US
Party NameBio X Cell
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLebanon, NH 03766
US
Party NameBio X Cell
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Lebanon, NH 03784
US

Trademark Events

Event DateEvent Description
Thursday, April 18, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 19, 2013NOTICE OF PSEUDO MARK E-MAILED
Monday, July 29, 2013ASSIGNED TO EXAMINER
Monday, July 29, 2013NON-FINAL ACTION WRITTEN
Monday, July 29, 2013NON-FINAL ACTION E-MAILED
Monday, July 29, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 31, 2013TEAS AMENDMENT OF USE RECEIVED
Thursday, August 1, 2013USE AMENDMENT FILED
Thursday, August 1, 2013AMENDMENT TO USE PROCESSING COMPLETE
Thursday, August 1, 2013USE AMENDMENT ACCEPTED
Thursday, August 1, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, August 1, 2013CORRESPONDENCE E-MAILED
Thursday, August 1, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, August 1, 2013APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, August 2, 2013NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, August 15, 2013ASSIGNED TO LIE
Thursday, August 15, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 17, 2013REGISTERED-SUPPLEMENTAL REGISTER
Monday, September 17, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 17, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 17, 2018TEAS SECTION 8 RECEIVED
Wednesday, September 19, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 19, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, September 19, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, September 17, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, November 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 13, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, February 23, 2024TEAS SECTION 8 & 9 RECEIVED
Wednesday, June 24, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Related Keywords

invivomab proteins carrier vivo scientific research azide contain namely monoclonal antibodies